Top

memo - Magazine of European Medical Oncology

Published in:

01-06-2022 | editorial

ESMO 2021

Author: Univ.-Prof. Dr. Rupert Bartsch

Published in: memo - Magazine of European Medical Oncology | Issue 2/2022

Excerpt

While still being held in a—largely—virtual format, the 2021 Congress of the European Society for Medical Oncology (ESMO) was a fascinating meeting and clinically relevant results have been reported in many areas of oncology. With regards to its scientific significance, it appears that the ESMO Congress today is on par with the American Society of Clinical Oncology (ASCO) Annual Meeting and therefore, this issue of MEMO provides a series of articles focusing on relevant results presented at the virtual 2021 ESMO congress in the fields of breast cancer, lung cancer, gastrointestinal and genitourinary cancers. …

Hutterer GC, Pichler M. Renal cell carcinoma—presentation highlights from the ESMO Congress 2021. memo. 2022;15(2). https://doi.org/10.1007/s12254-022-00798-6.CrossRef

Weiss L. ESMO 2021—highlights in colorectal cancer. memo. 2022;15(2). https://doi.org/10.1007/s12254-022-00808-7.CrossRefPubMedPubMedCentral

Rauter M. Highlights ESMO 2021—lung cancer. memo. 2022;15(2). https://doi.org/10.1007/s12254-022-00801-0.CrossRef

Suppan C. ESMO 2021—my top three abstracts in breast cancer. memo. 2022;15(2). https://doi.org/10.1007/s12254-022-00810-z.CrossRefPubMedPubMedCentral

Title: ESMO 2021
Author: Univ.-Prof. Dr. Rupert Bartsch
Publication date: 01-06-2022
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 2/2022
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-022-00807-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2022

Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature

Renal cell carcinoma—presentation highlights from the ESMO Congress 2021

Breast Cancer—Essential news of current guidelines

Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab

Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022

Tracking mutation and drug-driven alterations of oncokinase conformations

Keynote webinar | Spotlight on antibody–drug conjugates in cancer